Hinge Health Inc. (NYSE:HNGE) Stock Has Average Price Target of $108.00

Shares of Hinge Health Inc. (NYSE:HNGE) have earned an average rating of “Moderate Buy” from the nineteen analysts that are presently covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $118.93.

HNGE has been the topic of a number of research analyst reports. Royal Bank Of Canada raised their price target on shares of Hinge Health from $110.00 to $135.00 and gave the company an “outperform” rating in a research note on Tuesday. Bank of America assumed coverage on Hinge Health in a report on Tuesday, September 29th. They issued a “buy” rating and a $110.00 price objective for the company. Evercore restated an “outperform” rating and set a $105.00 price target on shares of Hinge Health in a report on Wednesday, August 5th. Wall Street Zen lowered Hinge Health from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Robert W. Baird boosted their price objective on Hinge Health from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Tuesday, September 22nd.

Hinge Health Stock Performance

Hinge Health stock opened at $120.78 on Thursday. Hinge Health has a 52 week low of $30.08 and a 52 week high of $124.94. The stock has a market capitalization of $9.75 billion, a P/E ratio of 61.62 and a beta of 1.19. The stock has a fifty day moving average of $99.83 and a 200-day moving average of $68.10.

Hinge Health (NYSE:HNGE) last released its quarterly earnings data on Monday, November 2nd. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.44. Hinge Health had a return on equity of 73.91% and a net margin of 21.02%. The business had revenue of $234.97 million for the quarter. During the same period last year, the business earned ($0.02) earnings per share. The business’s quarterly revenue was up 52.4% compared to the same quarter last year. On average, research analysts forecast that Hinge Health will post 1.25 earnings per share for the current year.

Insiders Place Their Bets

In other Hinge Health news, CEO Daniel Perez sold 150,000 shares of Hinge Health stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $89.44, for a total value of $13,416,000.00. Following the completion of the sale, the chief executive officer directly owned 35,470 shares of the company’s stock, valued at approximately $3,172,436.80. The trade was a 80.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Gabriel Mecklenburg sold 250,000 shares of Hinge Health stock in a transaction on Friday, September 11th. The shares were sold at an average price of $88.97, for a total transaction of $22,242,500.00. Following the completion of the sale, the chairman directly owned 250,000 shares of the company’s stock, valued at approximately $22,242,500. The trade was a 50.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,024,581 shares of company stock valued at $95,632,761 in the last ninety days. 18.92% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Hinge Health

Several institutional investors have recently modified their holdings of HNGE. IFP Advisors Inc grew its position in shares of Hinge Health by 140.0% during the 2nd quarter. IFP Advisors Inc now owns 324 shares of the company’s stock valued at $27,000 after acquiring an additional 189 shares during the period. Nykredit A S bought a new position in Hinge Health in the 2nd quarter worth $29,000. SBI Securities Co. Ltd. raised its holdings in Hinge Health by 39.5% in the 3rd quarter. SBI Securities Co. Ltd. now owns 364 shares of the company’s stock worth $35,000 after purchasing an additional 103 shares during the period. Sterling Capital Management LLC lifted its position in Hinge Health by 899.3% during the third quarter. Sterling Capital Management LLC now owns 1,469 shares of the company’s stock valued at $143,000 after purchasing an additional 1,322 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC purchased a new position in Hinge Health during the third quarter valued at $204,000.

Key Hinge Health News

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Strong Q3 results: Revenue rose 52% year over year to about $235 million, beating analyst estimates, while earnings per share also exceeded consensus. Hinge Health revenue jumps 52% in Q3
• Positive Sentiment: Raised outlook: Hinge Health forecast Q4 revenue of $249 million–$251 million and full-year 2026 revenue of $879 million–$881 million, both above analyst expectations. Hinge Health outlines 2026 revenue outlook
• Positive Sentiment: Analyst optimism: Morgan Stanley, Truist, RBC, Canaccord and Stifel raised their price targets after the results; each maintained a favorable rating, adding support to the bullish outlook.
• Positive Sentiment: Expansion opportunities: The company is broadening beyond musculoskeletal care into areas such as migraine and gastrointestinal programs, and is considering hardware acquisitions—potential avenues for future growth. Hinge Health expansion plans
• Negative Sentiment: Valuation risk: HNGE’s 156% year-to-date advance and trading near its high may leave the stock vulnerable if future growth or results fail to meet elevated expectations. Hinge Health stock looks stretched after its 156% YTD run

Hinge Health Company Profile

Hinge Health is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care programs designed to help members manage pain, improve mobility and reduce the need for more costly or invasive treatments.

Its platform combines personalized exercise therapy, behavioral support, education and access to clinical professionals. Hinge Health also uses technologies such as motion-sensing wearable devices and artificial intelligence to help guide exercises, monitor progress and tailor care plans to individual needs.

Hinge Health primarily serves employers and health plans, which offer its programs to eligible members in the United States.